Bonk (NASDAQ:BNKK – Get Free Report) is one of 344 public companies in the “Financial Services” industry, but how does it weigh in compared to its peers? We will compare Bonk to similar companies based on the strength of its valuation, earnings, profitability, risk, analyst recommendations, institutional ownership and dividends.
Analyst Ratings
This is a summary of recent ratings and price targets for Bonk and its peers, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bonk | 1 | 0 | 0 | 0 | 1.00 |
| Bonk Competitors | 1891 | 6816 | 11538 | 414 | 2.51 |
As a group, “Financial Services” companies have a potential upside of 3.86%. Given Bonk’s peers stronger consensus rating and higher probable upside, analysts plainly believe Bonk has less favorable growth aspects than its peers.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Bonk | -952.21% | -137.47% | -122.67% |
| Bonk Competitors | -407.45% | -22.01% | -5.65% |
Insider & Institutional Ownership
12.6% of Bonk shares are held by institutional investors. Comparatively, 43.2% of shares of all “Financial Services” companies are held by institutional investors. 51.6% of Bonk shares are held by insiders. Comparatively, 21.9% of shares of all “Financial Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Volatility & Risk
Bonk has a beta of 2.04, suggesting that its share price is 104% more volatile than the S&P 500. Comparatively, Bonk’s peers have a beta of 2.26, suggesting that their average share price is 126% more volatile than the S&P 500.
Earnings and Valuation
This table compares Bonk and its peers revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Bonk | $2.12 million | -$68.19 million | -0.37 |
| Bonk Competitors | $6.73 billion | $1.09 billion | 9.25 |
Bonk’s peers have higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
Bonk peers beat Bonk on 12 of the 13 factors compared.
Bonk Company Profile
Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
